Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 218.00
+3.70 (1.73%)
At close: Feb 12, 2026
Bliss GVS Pharma Employees
Bliss GVS Pharma had 966 employees as of March 31, 2025. The number of employees increased by 135 or 16.25% compared to the previous year.
Employees
966
Change (1Y)
135
Growth (1Y)
16.25%
Revenue / Employee
8.91M INR
Profits / Employee
1.13M INR
Market Cap
23.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 966 | 135 | 16.25% |
| Mar 31, 2024 | 831 | 68 | 8.91% |
| Mar 31, 2023 | 763 | 13 | 1.73% |
| Mar 31, 2022 | 750 | 67 | 9.81% |
| Mar 31, 2021 | 683 | 20 | 3.02% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Unichem Laboratories | 3,142 |
| Hikal | 2,062 |
| Lincoln Pharmaceuticals | 1,853 |
| Morepen Laboratories | 1,814 |
| Gufic Biosciences | 1,484 |
| TTK Healthcare | 1,339 |
| Kwality Pharmaceuticals | 997 |
| Syncom Formulations (India) | 744 |
Bliss GVS Pharma News
- 3 months ago - Bliss GVS Pharma shares fall over 15% today as EBITDA drops 20% and margins shrink to 13% - Business Upturn
- 3 months ago - Bliss GVS Pharma Q2 results: Net profit up 2.5% to Rs 25.69 crore; EBITDA down 20%, margin contracts to 13% - Business Upturn
- 10 months ago - Bliss GVS Clarifies USFDA ANDA Approval for Mesalamine Suppositories - Business Upturn
- 1 year ago - Bliss GVS Pharma shares surge 4% after company receives GMP Compliance certification for its manufacturing facilities in Palghar - Business Upturn
- 1 year ago - Bliss GVS Pharma receives GMP Compliance certification for manufacturing facilities in Palghar, Maharashtra - Business Upturn